Targeted therapies: Role of sorafenib in HCC patients with compromised liver function

Nat Rev Clin Oncol. 2009 Sep;6(9):505-6. doi: 10.1038/nrclinonc.2009.114.
No abstract available

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Benzenesulfonates / therapeutic use*
  • Carcinoma, Hepatocellular / pathology*
  • Carcinoma, Hepatocellular / therapy*
  • Clinical Trials, Phase III as Topic
  • Fibrosis / pathology
  • Humans
  • Liver Neoplasms / pathology*
  • Liver Neoplasms / therapy*
  • Niacinamide / analogs & derivatives
  • Phenylurea Compounds
  • Practice Guidelines as Topic
  • Pyridines / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Sorafenib
  • Survival Analysis
  • Time Factors

Substances

  • Antineoplastic Agents
  • Benzenesulfonates
  • Phenylurea Compounds
  • Pyridines
  • Niacinamide
  • Sorafenib